CRP and infection: Motivated by prior findings that MPSs for inflammatory markers such as CRP may capture more sustained inflammation compared to serum levels of these markers, and show utility as predictors of disease risk (Ligthart et al., 2016 Dec 12; Wielscher et al., 2022 May 3; Barker et al., 2018 Aug; Conole et al., 2023 Mar; Hillary et al., 2023; Green et al., 2021 Feb), we sought to develop an MPS of prenatal infections based on cord blood DNAm at birth.